Co-treating opioid and alcohol use disorders in the United States, 1960–2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era. // Drug and Alcohol Dependence Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2772724626000673?dgcid=rss_sd_all
Co-treating opioid and alcohol use disorders in the United States, 1960–2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era. Drug and Alcohol Dependence Reports. https://www.sciencedirect.com/science/article/pii/S2772724626000673?dgcid=rss_sd_all
“Co-treating opioid and alcohol use disorders in the United States, 1960–2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era.” Drug and Alcohol Dependence Reports.
@article{article43436,
title = {Co-treating opioid and alcohol use disorders in the United States, 1960–2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era},
journal = {Drug and Alcohol Dependence Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2772724626000673?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Mihailo Petrovic, Ann-Katrin Stensdotter, Helena Grip
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Michael Croskery, Victor Chan, Ryan B. Graham